When Medical Law International was launched in 1993, its stated aims were to provide a forum within which to examine new developments and enhance understanding of the often contentious issues that underlie medicine and law in the modern world, and to thereby stimulate debate and the generation of new knowledge.
1. While we are thankful to Shaun Pattinson and the outgoing team at ABA Publishing, as well as the incoming team at SAGE Publishing, for making the transition in management as smooth as it has been, we are particularly thankful to Sheila McLean whose efforts as Book Review Editor to secure expert and informed reviewers on new books will be maintained.
new and emerging issues in medical law and ethics around the world, and we encourage scholars to submit manuscripts addressing the following topics, which reflect the breadth and scope of medicine and health care generally:
social, ethical and legal issues in reproductive medicine, including genetic testing and screening; social, ethical and legal issues in medical treatment, including cellular therapies; social, ethical and legal issues concerning mental health; social, ethical and legal issues concerning medical research, including cloning, tissue and data banking, and related topics; medical complaints and procedures and clinical negligence; development, regulation, use and misuse of drugs, medical devices and medical products; organ and tissue donation and transplantation; confidentiality and access to medical records; professional discipline; forensic medicine, determination of death, and end of life decisions; health matters affecting civil liberties and human rights; and legal issues within healthcare systems, including resource allocation.
As before, the current regime change will not translate into 'all change' at Medical Law International, but rather to positive evolution built on the hard work of the past. Perhaps unsurprisingly, however, some change is to be expected. The most significant and obvious change is the coinciding takeover by a new publisher, SAGE Publications. SAGE is an independent international publisher of journals, books and electronic media, known for its commitment to quality and innovation. Together with SAGE, we are planning a number of initiatives aimed at expanding the reach and readership of the journal. For example: An online submission system, SAGE Track, will be adopted. It will provide a better service to authors and referees, who will be able to perform their tasks and track article progress through the Author Services function. All content, old and new, will be available to subscribers online (in html and pdf formats). The table of contents and abstracts for every issue will be made available online, at no cost, to the wider world. New submissions will benefit from an OnlineFirst function. All articles, including shorter critique or analysis pieces, will be fully peer reviewed and edited before being published online under OnlineFirst, and subsequently rolled into their earmarked issue, at which time they will receive their full reference information, including page numbers. This initiative in particular represents our commitment to making quality scholarship accessible to the academic and policy communities as quickly as possible. The journal will benefit from a new and more dynamic cover, and, as foreshadowed above, a new and more interactive web presence, which will include updated author instructions and formatting/style guides.
We are very excited and optimistic about this new partnership and what it will mean for the future of Medical Law International. It is also important to acknowledge what it will not mean. In particular, we are collectively committed to ensuring that, unlike some other journals, Medical Law International will not become the preserve of a select cadre of scholars. As such, we will continue to encourage submissions from scholars from around the world, including contributions from early career researchers, doctoral candidates, and policy makers. As in the past, our sole criteria for accepting submissions will be (i) social, ethical and legal interest/relevance and (ii) scholarly merit. Additionally, and again importantly, Medical Law International will not be (or become) doctrinally bound. Reflecting the diversity of medicine-and health-related issues generally, we encourage submissions with diverse theoretical and methodological roots, including empirical socio-legal and comparative research, and interdisciplinary scholarship. That having been said, the basic format of the journal will remain the same.
Our final message must be that we, once again, thank the outgoing editorial team, Shaun and Vivien, and look forward to the future of and with Medical Law International!
